|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Alcon Research |
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00047593 |
Purpose
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.
| Condition | Intervention | Phase |
|
Open-Angle Glaucoma Ocular Hypertension |
Drug: IOP Lowering Medications |
Phase III |
| Genetics Home Reference related topics: | early-onset glaucoma |
| MedlinePlus related topics: | Glaucoma High Blood Pressure |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98. |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Adults of Japanese Ethnicity
Contacts and Locations
More Information
| Study ID Numbers: | C-01-98, C-01-98 |
| First Received: | October 8, 2002 |
| Last Updated: | August 4, 2008 |
| ClinicalTrials.gov Identifier: | NCT00047593 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|